Lee C H, Ziegler J B, Rozenberg M C
Aust N Z J Med. 1979 Oct;9(5):530-3. doi: 10.1111/j.1445-5994.1979.tb03389.x.
A study was performed on the family of a child with severe combined immunodeficiency and deficiency of the purine salvage pathway enzyme, adenosine deaminase (ADA). Sixteen relatives over three generations were studied. Erythrocyte ADA levels clearly indicated the heterozygous status of five members. A sixth member, whose erythrocyte ADA level of 48 nmol/hr/ml Hb was within two standard deviations (32) of the mean (76) was shown by ADA determination on platelets to be clearly heterozygous. Similarly, consideration of ADA data of either serum, platelets or lymphocytes only, would have failed to identify all heterozygotes. The survey shows that the identification of phenotype by the indirect means of enzyme level determination is enhanced by the simultaneous study of several tissues.
对一名患有严重联合免疫缺陷且嘌呤补救途径酶腺苷脱氨酶(ADA)缺乏的儿童的家族进行了一项研究。研究了三代中的16名亲属。红细胞ADA水平清楚地表明了5名成员的杂合状态。第六名成员,其红细胞ADA水平为48 nmol/小时/毫升血红蛋白,在平均值(76)的两个标准差(32)范围内,通过对血小板进行ADA测定显示其明显为杂合子。同样,仅考虑血清、血小板或淋巴细胞的ADA数据,将无法识别所有杂合子。该调查表明,通过同时研究多个组织,利用酶水平测定这种间接方法来鉴定表型的准确性得到了提高。